Apollo Hospitals Enterprise Limited (APOLLOHOSP) Fair Value & Analysis
Healthcare · IN · Market cap ₹1.3T (≈ $13.5B) · ISIN INE437A01024
What is Apollo Hospitals Enterprise Limited really worth?
A solid business, but trading 65% above our fair value of ₹5,234.
Strengths
Risks
For context
Fair value as of: Aug 19, 2026
From 26 valuation models · updated 16 days ago
Fair value updated Aug 19, 2026, revised from ₹2,908 to ₹5,234 (+80.0%) since Aug 13, 2026. Share price −2.9% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case (₹7,808). The favourable scenario is already priced in.
- The model range is unusually wide (₹2,483 to ₹7,808). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid but not exceptional quality (58/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 19, 2026.
How to read this chart
60‑month range ₹3,109 – ₹9,050 · fair‑value band ₹2,483 – ₹7,808 · the ₹8,650 price screens above the ₹5,234 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 19, 2026.
Analysis
Apollo Hospitals Enterprise Limited (APOLLOHOSP) currently trades at ₹8,650, while our model-based Fair Value estimate is ₹5,234, implying the stock looks roughly 65.3% overvalued today. The Quality Score stands at 58/100 (solid quality), in the Healthcare sector. Bull case: the Growth Earnings group reads highest at a median of ₹3,337 per share, and 0 of the 26 models we run sit above the ₹8,650 price. Bear case: the Economic Profit group reads lowest at ₹1,330, and 26 of the 26 models stay below the price. Evidence for this calculation is medium.
Over the trailing twelve months, Apollo Hospitals Enterprise Limited generated revenue of ₹252B at a net margin of 7.7%. Revenue grew 18.1% year over year. It earns a return on equity of 21.5%. Net debt stands at ₹73.8B. Fundamentals as of Aug 19, 2026
Our scenario range runs from ₹2,483 (bear case) to ₹7,808 (bull case); at ₹8,650, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 29% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −39%, APOLLOHOSP screens richer than that median.
Fair Value models
This estimate rests on fiscal year 2026 figures, and about 5 months have passed since. In that time the company retained roughly ₹49.90 per share, which is 1.0 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 26 models by family
Widest divergence: Growth Earnings (₹3,337) versus Dividend Discount (₹344.08). Highest evidence: EPV (74).
Notify me when APOLLOHOSP reaches fair value
Put APOLLOHOSP on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 57 · Market factors (momentum, volatility) 69
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities.
Full company description
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, oncology, neurosciences, gastroenterology, orthopedics, urology, organ transplantation, pulmonology, obstetrics and gynecology, internal medicine, vascular surgery, pediatrics, cosmetology, emergency medicine, bariatric surgery, general surgery, colorectal surgery, dentistry, nephrology, dermatology, endocrinology, preventive medicine, interventional radiology, ophthalmology, and integrative medicine, as well as robotic surgery and genomics. The company also provides project consultancy, medical educational institutes, Medvarsity for e-learning, and research services, as well as acts as an agent for life, general, and health insurance. In addition, it operates hospitals, pharmacies, primary care clinics, and diagnostic centers; short stay facilities, boutique birthing centers, multi-specialty clinics, dental and dialysis facilities, and preventive care; day surgery, diabetes management, and cradle and fertility centers; and Apollo 24/7, a digital health mobile platform that provides teleconsultations, online pharmacy deliveries, home diagnostics, and insurance services. Further, the company engages in the business of bio-banking of tissues. It serves patients, corporate clients, and the government and public sectors. Apollo Hospitals Enterprise Limited was incorporated in 1979 and is based in Chennai, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Apollo Hospitals Enterprise Limited reported revenue of ₹252B in FY2026 versus ₹147B in FY2022, a compound +14.5%/yr. Reported net income was ₹19.4B in FY2026, compounding +16.5%/yr from FY2022.
of which total revenue +15.1 % · buybacks/dilution −0.4 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
APOLLOHOSP screens 65% overvalued. Compare with HCA Healthcare, Inc →
Earlier news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Apollo’s Torsten Sløk Sees Growing Risks Beyond Tech Stocks
- Indian hospital chain Apollo beats quarterly profit view on high demand for specialty care
- India’s Apollo Hospitals to secure IFC’s stake in Apollo Health and Lifestyle
Peer Group
Medical Care Facilities · 257 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $417.82 | $547.67 | +31% |
| Fresenius SE FRE | €45.25 | €32.15 | −29% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 241.00 SAR | 112.37 SAR | −53% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.67 SGD | 1.44 SGD | −46% |
| Tenet Healthcare Corporation THC | $266.80 | $330.25 | +24% |
| DaVita Inc DVA | $180.68 | $186.49 | +3% |
| Fresenius Medical Care AG FME | €39.92 | €71.28 | +79% |
| Aier Eye Hospital Group 300015 | ¥8.25 | ¥7.67 | −7% |
| Max Healthcare Institute Limited MAXHEALTH | ₹1,005 | ₹284.87 | −72% |
| Encompass Health Corporation EHC | $120.31 | $109.77 | −9% |
Compare Apollo Hospitals Enterprise Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Apollo Hospitals Enterprise Limited (APOLLOHOSP) overvalued or undervalued?
What is the fair value of APOLLOHOSP?
What is the quality score of APOLLOHOSP?
What is the revenue of Apollo Hospitals Enterprise Limited (APOLLOHOSP)?
What is the net profit margin of APOLLOHOSP?
Does Apollo Hospitals Enterprise Limited pay a dividend?
Watch Apollo Hospitals Enterprise Limited in the live analysis
One click puts Apollo Hospitals Enterprise Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.